PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer

McCubrey, James A.2022-02-042022-02-042017-02-212045-2322http://hdl.handle.net/10342/9643en-USPTENMEK and mTOR inhibitioncancerPTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancerArticle10.1038/srep43013